-
1
-
-
45949103309
-
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, G. Palareti Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 160S 198S
-
(2008)
Chest
, vol.133
-
-
Ansell, J.1
Hirsh, J.2
Hylek, E.3
Jacobson, A.4
Crowther, M.5
Palareti, G.6
-
2
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, L. Wallentin Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
Pogue, J.7
Reilly, P.A.8
Themeles, E.9
Varrone, J.10
Wang, S.11
Alings, M.12
Xavier, D.13
Zhu, J.14
Diaz, R.15
Lewis, B.S.16
Darius, H.17
Diener, H.C.18
Joyner, C.D.19
Wallentin, L.20
more..
-
3
-
-
67849126841
-
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents
-
M.A. Crowther, T.E. Warkentin Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents J Thromb Haemost 7 Suppl 1 2009 107 110
-
(2009)
J Thromb Haemost
, vol.7
, Issue.SUPPL. 1
, pp. 107-110
-
-
Crowther, M.A.1
Warkentin, T.E.2
-
4
-
-
80053571188
-
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects
-
E.S. Eerenberg, P.W. Kamphuisen, M.K. Sijpkens, J.C. Meijers, H.R. Buller, M. Levi Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
-
(2011)
Circulation
, vol.124
, pp. 1573-1579
-
-
Eerenberg, E.S.1
Kamphuisen, P.W.2
Sijpkens, M.K.3
Meijers, J.C.4
Buller, H.R.5
Levi, M.6
-
5
-
-
79958126202
-
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
-
J.W. Eikelboom, L. Wallentin, S.J. Connolly, M. Ezekowitz, J.S. Healey, J. Oldgren, S. Yang, M. Alings, S. Kaatz, S.H. Hohnloser, H.C. Diener, M.G. Franzosi, K. Huber, P. Reilly, J. Varrone, S. Yusuf Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial Circulation 123 2011 2363 2372
-
(2011)
Circulation
, vol.123
, pp. 2363-2372
-
-
Eikelboom, J.W.1
Wallentin, L.2
Connolly, S.J.3
Ezekowitz, M.4
Healey, J.S.5
Oldgren, J.6
Yang, S.7
Alings, M.8
Kaatz, S.9
Hohnloser, S.H.10
Diener, H.C.11
Franzosi, M.G.12
Huber, K.13
Reilly, P.14
Varrone, J.15
Yusuf, S.16
-
6
-
-
34548575058
-
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: A randomised, double-blind, noninferiority trial
-
RE-NOVATE Study Group
-
B.I. Eriksson, O.E. Dahl, N. Rosencher, N. Rosencher, A.A. Kurth, C.N. van Dijk, S.P. Frostick, M.H. Prins, R. Hettiarachchi, S. Hantel, J. Schnee, H.R. Büller RE-NOVATE Study Group Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, noninferiority trial Lancet 370 2007 949 956
-
(2007)
Lancet
, vol.370
, pp. 949-956
-
-
Eriksson, B.I.1
Dahl, O.E.2
Rosencher, N.3
Rosencher, N.4
Kurth, A.A.5
Van Dijk, C.N.6
Frostick, S.P.7
Prins, M.H.8
Hettiarachchi, R.9
Hantel, S.10
Schnee, J.11
Büller, H.R.12
-
7
-
-
79953836474
-
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*) A randomised, double-blind, noninferiority trial
-
RE-NOVATE II Study Group
-
B.I. Eriksson, O.E. Dahl, M.H. Huo, A.A. Kurth, S. Hantel, K. Hermansson, J.M. Schnee, R.J. Friedman RE-NOVATE II Study Group Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*) A randomised, double-blind, noninferiority trial Thromb Haemost 105 2011 721 729
-
(2011)
Thromb Haemost
, vol.105
, pp. 721-729
-
-
Eriksson, B.I.1
Dahl, O.E.2
Huo, M.H.3
Kurth, A.A.4
Hantel, S.5
Hermansson, K.6
Schnee, J.M.7
Friedman, R.J.8
-
8
-
-
79551638273
-
Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism
-
B.I. Eriksson, D.J. Quinlan, J.W. Eikelboom Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism Annu Rev Med 62 2011 41 57
-
(2011)
Annu Rev Med
, vol.62
, pp. 41-57
-
-
Eriksson, B.I.1
Quinlan, D.J.2
Eikelboom, J.W.3
-
9
-
-
84855611604
-
Dabigatran in atrial fibrillation: Pharmacology and clinical trials
-
M.D. Ezekowitz, R. Nagarakanti Dabigatran in atrial fibrillation: pharmacology and clinical trials J Interv Card Electrophysiol 32 2011 173 180
-
(2011)
J Interv Card Electrophysiol
, vol.32
, pp. 173-180
-
-
Ezekowitz, M.D.1
Nagarakanti, R.2
-
10
-
-
46049090201
-
Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, M.R. Lassen, C.W. Colwell Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 381S 453S
-
(2008)
Chest
, vol.133
-
-
Geerts, W.H.1
Bergqvist, D.2
Pineo, G.F.3
Heit, J.A.4
Samama, C.M.5
Lassen, M.R.6
Colwell, C.W.7
-
11
-
-
79951688186
-
Changing anticoagulant paradigms for atrial fibrillation: Dabigatran, apixaban and rivaroxaban
-
M.A. Giorgi, H. Cohen Arazi, C.D. Gonzalez, G. Di Girolamo Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban Expert Opin Pharmacother 12 2011 567 577
-
(2011)
Expert Opin Pharmacother
, vol.12
, pp. 567-577
-
-
Giorgi, M.A.1
Cohen Arazi, H.2
Gonzalez, C.D.3
Di Girolamo, G.4
-
12
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
ARISTOTLE Committees and Investigators
-
C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, H.R. Al-Khalidi, J. Ansell, D. Atar, A. Avezum, M.C. Bahit, R. Diaz, J.D. Easton, J.A. Ezekowitz, G. Flaker, D. Garcia, M. Geraldes, B.J. Gersh, S. Golitsyn, S. Goto, A.G. Hermosillo, S.H. Hohnloser, J. Horowitz, P. Mohan, P. Jansky, B.S. Lewis, J.L. Lopez-Sendon, P. Pais, A. Parkhomenko, F.W. Verheugt, J. Zhu, L. Wallentin ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 982
-
(2011)
N Engl J Med
, vol.365
, pp. 981-982
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
Lopes, R.D.4
Hylek, E.M.5
Hanna, M.6
Al-Khalidi, H.R.7
Ansell, J.8
Atar, D.9
Avezum, A.10
Bahit, M.C.11
Diaz, R.12
Easton, J.D.13
Ezekowitz, J.A.14
Flaker, G.15
Garcia, D.16
Geraldes, M.17
Gersh, B.J.18
Golitsyn, S.19
Goto, S.20
Hermosillo, A.G.21
Hohnloser, S.H.22
Horowitz, J.23
Mohan, P.24
Jansky, P.25
Lewis, B.S.26
Lopez-Sendon, J.L.27
Pais, P.28
Parkhomenko, A.29
Verheugt, F.W.30
Zhu, J.31
Wallentin, L.32
more..
-
13
-
-
79954456496
-
Dabigatran etexilate: A new oral thrombin inhibitor
-
G.J. Hankey, J.W. Eikelboom Dabigatran etexilate: a new oral thrombin inhibitor Circulation 123 2011 1436 1450
-
(2011)
Circulation
, vol.123
, pp. 1436-1450
-
-
Hankey, G.J.1
Eikelboom, J.W.2
-
14
-
-
36549087247
-
Status of the epidemiology of atrial fibrillation
-
W.B. Kannel, E.J. Benjamin Status of the epidemiology of atrial fibrillation Med Clin North Am 92 2008 17 40
-
(2008)
Med Clin North Am
, vol.92
, pp. 17-40
-
-
Kannel, W.B.1
Benjamin, E.J.2
-
15
-
-
33750023407
-
Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: A population model analysis
-
K.H. Liesenfeld, H.G. Schafer, I.F. Troconiz, C. Tillmann, B.I. Eriksson, J. Stangier Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis Br J Clin Pharmacol 62 2006 527 537
-
(2006)
Br J Clin Pharmacol
, vol.62
, pp. 527-537
-
-
Liesenfeld, K.H.1
Schafer, H.G.2
Troconiz, I.F.3
Tillmann, C.4
Eriksson, B.I.5
Stangier, J.6
-
16
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
ROCKET AF Investigators
-
M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, R.M. Califf ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
Pan, G.4
Singer, D.E.5
Hacke, W.6
Breithardt, G.7
Halperin, J.L.8
Hankey, G.J.9
Piccini, J.P.10
Becker, R.C.11
Nessel, C.C.12
Paolini, J.F.13
Berkowitz, S.D.14
Fox, K.A.15
Califf, R.M.16
-
17
-
-
71849117615
-
Dabigatran versus warfarin in the treatment of acute venous thromboembolism
-
RE-COVER Study Group
-
S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, H. Eriksson, D. Baanstra, J. Schnee, S.Z. Goldhaber RE-COVER Study Group Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
-
(2009)
N Engl J Med
, vol.361
, pp. 2342-2352
-
-
Schulman, S.1
Kearon, C.2
Kakkar, A.K.3
Mismetti, P.4
Schellong, S.5
Eriksson, H.6
Baanstra, D.7
Schnee, J.8
Goldhaber, S.Z.9
-
18
-
-
45949095568
-
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
D.E. Singer, G.W. Albers, J.E. Dalen, M.C. Fang, A.S. Go, J.L. Halperin, G.Y. Lip, W.J. Manning Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 546S 592S
-
(2008)
Chest
, vol.133
-
-
Singer, D.E.1
Albers, G.W.2
Dalen, J.E.3
Fang, M.C.4
Go, A.S.5
Halperin, J.L.6
Lip, G.Y.7
Manning, W.J.8
-
19
-
-
77953168824
-
Dabigatran etexilate - A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
-
J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, M. Feuring, A. Clemens Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
-
(2010)
Thromb Haemost
, vol.103
, pp. 1116-1127
-
-
Van Ryn, J.1
Stangier, J.2
Haertter, S.3
Liesenfeld, K.H.4
Wienen, W.5
Feuring, M.6
Clemens, A.7
-
20
-
-
84856807170
-
Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment
-
M. Watanabe, F.M. Siddiqui, A.I. Qureshi Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment Neurocrit Care 16 2012 203 209
-
(2012)
Neurocrit Care
, vol.16
, pp. 203-209
-
-
Watanabe, M.1
Siddiqui, F.M.2
Qureshi, A.I.3
-
21
-
-
44949133339
-
Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation
-
W.E. Wysokinski, R.D. McBane, P.R. Daniels, S.C. Litin, D.O. Hodge, N.F. Dowling, J.A. Heit Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation Mayo Clin Proc 83 2008 639 645
-
(2008)
Mayo Clin Proc
, vol.83
, pp. 639-645
-
-
Wysokinski, W.E.1
McBane, R.D.2
Daniels, P.R.3
Litin, S.C.4
Hodge, D.O.5
Dowling, N.F.6
Heit, J.A.7
|